Compliance Checklists No Longer Required at Initial Manuscript Submission. Read more about Compliance Checklists No Longer Required at Initial Manuscript Submission.
Characterization of Prenylated C-terminal Peptides Using a Thiopropyl-based Capture Technique and LC-MS/MS. Read more about Characterization of Prenylated C-terminal Peptides Using a Thiopropyl-based Capture Technique and LC-MS/MS.
Quantitative Proteomics of Uukuniemi Virus-host Cell Interactions Reveals GBF1 as Proviral Host Factor for Phleboviruses. Read more about Quantitative Proteomics of Uukuniemi Virus-host Cell Interactions Reveals GBF1 as Proviral Host Factor for Phleboviruses.
The Identification of Novel Potential Injury Mechanisms and Candidate Biomarkers in Renal Allograft Rejection by Quantitative Proteomics. Read more about The Identification of Novel Potential Injury Mechanisms and Candidate Biomarkers in Renal Allograft Rejection by Quantitative Proteomics.
Matching Cross-linked Peptide Spectra: Only as Good as the Worse Identification. Read more about Matching Cross-linked Peptide Spectra: Only as Good as the Worse Identification.
Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma. Read more about Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma.
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. Read more about Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.
A Novel Mechanism for NF-κB-activation via IκB-aggregation: Implications for Hepatic Mallory-Denk-Body Induced Inflammation. Read more about A Novel Mechanism for NF-κB-activation via IκB-aggregation: Implications for Hepatic Mallory-Denk-Body Induced Inflammation.
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. Read more about Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.
